Synthego
AcquiredYour Partner in CRISPR & Molecular Diagnostics
Redwood City, United States · Founded 2012 · $468.6M raised
- Headquarters
- Redwood City, California
- Employees
- 51–200
- Founded
- 2012
- Business Model
- B2B
- Website
- synthego.com
- Total Funding
- $468.6M
- Last Round
- $200.0M Series EFeb 2022
- Rounds
- 7
- Acquisition Date
- Jul 2025
About
Synthego is a CRISPR solutions company that provides high-quality reagents, engineered cell lines, and GMP manufacturing services to accelerate life science research and therapeutic development. The company's full-stack genome engineering platform vertically integrates proprietary automation, bioinformatics, and molecular biology to support programs from discovery through clinical trials. Synthego serves thousands of academic and commercial researchers worldwide across gene editing, molecular diagnostics, and cell and gene therapy applications.
Summary
Synthego is a Biotech company based in Redwood City, United States, founded in 2012. It has raised $468.6M in total across 7 rounds, most recently a $200.0M Series E round in Feb 2022. Investors include Perceptive Advisors, 8VC and Menlo Ventures.
Tech & App Stack
20 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2025
Sign up to see all 8 rounds
Seed through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
.png)
Similar Companies
Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...
Life science company democratizing access to advanced DNA sequencing tools with high-quality, aff...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Clinical-stage biopharma mining fungal genomes to discover genetically-encoded small molecules fo...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/synthego"><img src="https://indexed.vc/api/badge/company/synthego" alt="Synthego on Indexed.vc" width="260" height="76" /></a>